Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Elizabeth D. Dalton, Laura E. Miller, Ivanka Pjesivac & Scott A. Eldredge. (2022) Information-seeking barriers and strategies in maternity care: a framework analysis of nurses’ goals, plans, and actions. Journal of Communication in Healthcare 15:3, pages 158-167.
Read now
Read now
Katrina Mark, Abraham Khan & Mishka Terplan. (2020) Cannabis Use as Determined by Biologic Testing in Maternal and Newborn Urines during a Period of Drug Liberalization. Substance Use & Misuse 55:8, pages 1343-1346.
Read now
Read now
Hallvard Gjerde, Linn Gjersing, Håvard Furuhaugen & Anne Line Bretteville-Jensen. (2019) Correspondence between Oral Fluid Drug Test Results and Self-Reported Illicit Drug Use among Music Festival Attendees. Substance Use & Misuse 54:8, pages 1337-1344.
Read now
Read now
Beth A. Bailey, Alyson Chroust, Darshan Shah, Nathaniel Justice & David Wood. Which newborns need monitoring for neonatal opioid withdrawal syndrome (NOWS)? Utilization and accuracy of methods to assess pregnancy opioid use. Journal of Substance Use 0:0, pages 1-6.
Read now
Read now
Articles from other publishers (35)
Suzanne Turner, Victoria M. Allen, Glenda Carson, Lisa Graves, Robert Tanguay, Courtney R. Green & Jocelynn L. Cook. (2023) Directive clinique no 443b : Opioïdes aux différentes étapes de la vie des femmes : Grossesse et allaitement. Journal of Obstetrics and Gynaecology Canada 45:11, pages 102146.
Crossref
Crossref
Suzanne Turner, Victoria M. Allen, Glenda Carson, Lisa Graves, Robert Tanguay, Courtney R. Green & Jocelynn L. Cook. (2023) Guideline No. 443b: Opioid Use Throughout Women’s Lifespan: Opioid Use in Pregnancy and Breastfeeding. Journal of Obstetrics and Gynaecology Canada 45:11, pages 102144.
Crossref
Crossref
Kathryn Polak, Nancy A. Haug, Pamela Dillon & Dace S. Svikis. (2023) Substance Use Disorders in Women. Psychiatric Clinics of North America 46:3, pages 487-503.
Crossref
Crossref
Sarah E. Maylott, Elisabeth Conradt, Monica McGrath, Emily A. Knapp, Xiuhong Li, Rashelle Musci, Judy Aschner, Lyndsay A. Avalos, Lisa A. Croen, Sean Deoni, Karen Derefinko, Amy Elliott, Julie A. Hofheimer, Leslie D. Leve, Juliette C. Madan, Maxwell Mansolf, Liza B. Murrison, Jenae M. Neiderhiser, Sally Ozonoff, Jonathan Posner, Amy Salisbury, Sheela Sathyanarayana, Julie B. Schweitzer, Carl Seashore, Meagan E. Stabler, Leslie W. Young, Steven J. Ondersma, Barry Lester, P.B. Smith, K.L. Newby, L.P. Jacobson, C.B. Parker, R. Gershon, D. Cella, F.P. Perera, J.B. Herbstman, M.R. Karagas, J. Ganiban, A. Ferrara, L.A. Croen, N. Paneth, J.M. Kerver, D.M. Ruden, S. Deoni, V.A. D’Sa, C. Blair, J.M. Neiderhiser, K.Z. LeWinn, N.R. Bush, D. Dabelea, M. O'Shea, R. Fry, L.D. Leve, A. Mason, J.B. Stanford, A. Giardino, C.A. Porucznik, C. Karr, S. Sathyanarayana, J. Gern, A.J. Elliott, I. Hertz-Picciotto, J.B. Schweitzer & D. Bennett. (2023) Latent Class Analysis of Prenatal Substance Exposure and Child Behavioral Outcomes. The Journal of Pediatrics 260, pages 113468.
Crossref
Crossref
Lylach Haizler-Cohen, Ana Collins, Dana M. Kaplan, Priyadarshani Giri, Adi Davidov, Jonathan Blau & Gary Fruhman. (2023) Universal Urine Drug Screening with Rapid Confirmation upon Admission to Labor and Delivery. American Journal of Perinatology.
Crossref
Crossref
Sarena Hayer, Ava D. Mandelbaum, Lester Watch, Kimberly S. Ryan, Madeline A. Hedges, Jennifer A. Manuzak, Charles A. Easley, Danny J. Schust & Jamie O. Lo. (2023) Cannabis and Pregnancy: A Review. Obstetrical & Gynecological Survey 78:7, pages 411-428.
Crossref
Crossref
Amanda F. Lowell, Nancy E. Suchman, Nancy Byatt, Emily Feinberg, Peter D. Friedmann & Elizabeth Peacock‐Chambers. (2023) Parental substance use and home visiting programs: Implementation considerations for relationship‐based treatment. Infant Mental Health Journal 44:2, pages 166-183.
Crossref
Crossref
Abdulazeez Towobola, Basirat Towobola, Bosky Nair & Arti Makwana. (2021) The ethics and management of cannabis use in pregnancy following decriminalisation and licensing for medical use: narrative review. BJPsych Bulletin 47:1, pages 28-37.
Crossref
Crossref
Kelsey C. CoyJean Y. KoSteven J. OndersmaKathryn Gilstad-HaydenLauren B. ZapataGrace ChangKimberly Yonkers. (2022) Association of Prepregnancy Substance Use and Substance Use Disorders with Pregnancy Timing and Intention. Journal of Women's Health 31:11, pages 1630-1638.
Crossref
Crossref
Janelle Liu, Karen Grewen & Wei Gao. (2022) Evidence for the Normalization Effects of Medication for Opioid Use Disorder on Functional Connectivity in Neonates with Prenatal Opioid Exposure. The Journal of Neuroscience 42:22, pages 4555-4566.
Crossref
Crossref
Kara R. Skelton, Erin Donahue & Sara E. Benjamin-Neelon. (2022) Validity of self-report measures of cannabis use compared to biological samples among women of reproductive age: a scoping review. BMC Pregnancy and Childbirth 22:1.
Crossref
Crossref
Natalie S. Levy, Joseph J. Palamar, Stephen J. Mooney, Charles M. Cleland & Katherine M. Keyes. (2022) What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates. Annals of Epidemiology 68, pages 45-53.
Crossref
Crossref
Constance GuilleLizmarie MaldonadoAnnie N. SimpsonRoger NewmanCourtney KingBernadette CorteseErin QuigleyNicole DietrichAnna KerrRubin AujlaKathryn KingDee FordKathleen T. Brady. (2021) A Non‐Randomized Trial of In‐Person Versus Text/Telephone Screening, Brief Intervention and Referral to Treatment for Pregnant and Postpartum Women. Psychiatric Research and Clinical Practice 3:4, pages 172-183.
Crossref
Crossref
Kelsey C. Coy, Sarah C. Haight, Erica Anstey, Althea M. Grant, Nan Ruffo & Jean Y. Ko. (2021) Postpartum Marijuana Use, Perceptions of Safety, and Breastfeeding Initiation and Duration: An Analysis of PRAMS Data From Seven States, 2017. Journal of Human Lactation 37:4, pages 803-812.
Crossref
Crossref
Preeti Kar, Lianne Tomfohr-Madsen, Gerald Giesbrecht, Mercedes Bagshawe & Catherine Lebel. (2021) Alcohol and substance use in pregnancy during the COVID-19 pandemic. Drug and Alcohol Dependence 225, pages 108760.
Crossref
Crossref
Sarah C. Haight, Brian A. King, Jennifer M. Bombard, Kelsey C. Coy, Cynthia D. Ferré, Althea M. Grant & Jean Y. Ko. (2021) Frequency of cannabis use during pregnancy and adverse infant outcomes, by cigarette smoking status – 8 PRAMS states, 2017. Drug and Alcohol Dependence 220, pages 108507.
Crossref
Crossref
Kira Bombay, Malia SQ Murphy, Kathryn M Denize, Christina Cantin, Amy McGee, Ruth Rennicks White, Shi Wu Wen, Mark C Walker & Daniel J Corsi. (2021) Receptiveness to participating in cannabis research in pregnancy: a survey study at The Ottawa Hospital. F1000Research 10, pages 413.
Crossref
Crossref
Roman Gabrhelík, Milada Mahic, Ingunn Olea Lund, Jørgen Bramness, Randi Selmer, Eva Skovlund, Marte Handal & Svetlana Skurtveit. (2021) Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study. European Addiction Research 27:2, pages 131-141.
Crossref
Crossref
Daniel J. Corsi, Jessy Donelle, Ewa Sucha, Steven Hawken, Helen Hsu, Darine El-Chaâr, Lise Bisnaire, Deshayne Fell, Shi Wu Wen & Mark Walker. (2020) Maternal cannabis use in pregnancy and child neurodevelopmental outcomes. Nature Medicine 26:10, pages 1536-1540.
Crossref
Crossref
Emmanuel A. Oga, Katrina Mark, Erica N. Peters & Victoria H. Coleman-Cowger. (2020) Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States. Journal of Addiction Medicine 14:5, pages 423-430.
Crossref
Crossref
Daniel J. Corsi, Helen Hsu, Deshayne B. Fell, Shi Wu Wen & Mark Walker. (2020) Association of Maternal Opioid Use in Pregnancy With Adverse Perinatal Outcomes in Ontario, Canada, From 2012 to 2018. JAMA Network Open 3:7, pages e208256.
Crossref
Crossref
Lisbet S. LundsbergMeredith J. PensakAileen M. Gariepy. (2020) Is Periconceptional Substance Use Associated with Unintended Pregnancy?. Women's Health Reports 1:1, pages 17-25.
Crossref
Crossref
Katrina Mark, Emily Pierce, Dania Joseph & Sarah Crimmins. (2020) Interaction with the justice system and other factors associated with pregnant women’s self-report and continuation of use of marijuana. Drug and Alcohol Dependence 206, pages 107723.
Crossref
Crossref
Daniel J. Corsi, Laura Walsh, Deborah Weiss, Helen Hsu, Darine El-Chaar, Steven Hawken, Deshayne B. Fell & Mark Walker. (2019) Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes. JAMA 322:2, pages 145.
Crossref
Crossref
Jeffrey Ecker, Alfred Abuhamad, Washington Hill, Jennifer Bailit, Brian T. Bateman, Vincenzo Berghella, Tiffany Blake-Lamb, Constance Guille, Ruth Landau, Howard Minkoff, Malavika Prabhu, Emily Rosenthal, Mishka Terplan, Tricia E. Wright & Kimberly A. Yonkers. (2019) Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. American Journal of Obstetrics and Gynecology 221:1, pages B5-B28.
Crossref
Crossref
Kathryn Polak, Sydney Kelpin & Mishka Terplan. (2019) Screening for substance use in pregnancy and the newborn. Seminars in Fetal and Neonatal Medicine 24:2, pages 90-94.
Crossref
Crossref
Daniel J. Corsi, Helen Hsu, Deborah Weiss, Deshayne B. Fell & Mark Walker. (2018) Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017. Canadian Journal of Public Health 110:1, pages 76-84.
Crossref
Crossref
Jocelynn L. Cook, Courtney R. Green, Sandra de la Ronde, Colleen A. Dell, Lisa Graves, Lisa Morgan, Alice Ordean, James Ruiter, Megan Steeves & Suzanne Wong. (2017) Screening and Management of Substance Use in Pregnancy: A Review. Journal of Obstetrics and Gynaecology Canada 39:10, pages 897-905.
Crossref
Crossref
Uma M. Reddy, Jonathan M. Davis, Zhaoxia Ren & Michael F. Greene. (2017) Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes. Obstetrics & Gynecology 130:1, pages 10-28.
Crossref
Crossref
Mary Beth Sutter, Sarah Gopman & Lawrence Leeman. (2017) Patient-centered Care to Address Barriers for Pregnant Women with Opioid Dependence. Obstetrics and Gynecology Clinics of North America 44:1, pages 95-107.
Crossref
Crossref
Curtis Bone, Lilian Gelberg, Mani Vahidi, Barbara Leake, Julia Yacenda-Murphy & Ronald M. Andersen. (2016) Under-reporting of Risky Drug Use Among Primary Care Patients in Federally Qualified Health Centers. Journal of Addiction Medicine 10:6, pages 387-394.
Crossref
Crossref
Michael G. McDonell, Meredith C. Graves, Imara I. West, Richard K. Ries, Dennis M. Donovan, Kristin Bumgardner, Antoinette Krupski, Chris Dunn, Charles Maynard, David C. Atkins & Peter Roy-Byrne. (2016) Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders. Journal of Addiction Medicine 10:3, pages 196-201.
Crossref
Crossref
Laura P. McLafferty, Madeleine Becker, Nehama Dresner, Samantha Meltzer-Brody, Priya Gopalan, Jody Glance, Guitelle St. Victor, Leena Mittal, Patrick Marshalek, Laura Lander & Linda L.M. Worley. (2016) Guidelines for the Management of Pregnant Women With Substance Use Disorders. Psychosomatics 57:2, pages 115-130.
Crossref
Crossref
Mahek Garg, Laura Garrison, Lawrence Leeman, Ajna Hamidovic, Matthew Borrego, William F. Rayburn & Ludmila Bakhireva. (2015) Validity of Self-Reported Drug Use Information Among Pregnant Women. Maternal and Child Health Journal 20:1, pages 41-47.
Crossref
Crossref
Kimberly A. Yonkers, Ariadna Forray, Heather B. Howell, Nathan Gotman, Trace Kershaw, Bruce J. Rounsaville & Kathleen M. Carroll. (2012) Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery. General Hospital Psychiatry 34:5, pages 439-449.
Crossref
Crossref